Guidant seeks US OK for cobalt chromium stent:

Executive Summary

Guidant has submitted to the US FDA a premarket approval (PMA) application for permission to market its Multi-Link Vision coronary stent system. The device, the company's seventh-generation Multi-Link stent platform for the treatment of coronary artery disease, is constructed of a cobalt chromium alloy, enabling the stent to have thinner stent struts and enhanced deliverability while maintaining "excellent" radial strength and visibility, says the firm. The company plans to use cobalt chromium stents in future drug eluting stent platforms.